Evidence map›Paper›PMID 23170002›Full record

ArticlemBio2012

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans.

Sander van Boheemen, Miranda de Graaf, Chris Lauber, Theo M Bestebroer, V Stalin Raj, Ali Moh Zaki, Albert D M E Osterhaus, Bart L Haagmans, Alexander E Gorbalenya, Eric J Snijder and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in mBio, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03615911 (An Open, Single Center Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of Two Ascending Doses of the Candidate Vaccine MVA-MERS-S), which is not on this map. Cited by 594 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
594citing papers in PubMed, 2 pooled it
44.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03615911 phase1completednot on this mapstarted 2017, after this paper: background citation

An Open, Single Center Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of Two Ascending Doses of the Candidate Vaccine MVA-MERS-S

TypeinterventionalSponsorMarylyn AddoRan2017 to 2019Enrolled26ConditionsMERS (Middle East Respiratory Syndrome)Armsvaccine candidate MVA-MERS-S
3 · Its place in the literature

Who cites it

594 citing papers in PubMed, 2 syntheses or guidelines pooled it, 941 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Human coronaviruses: activation and antagonism of innate immune responses.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  14. Perturbation ofJournal of virology · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

534 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Sander van BoheemenViroscience Lab, Erasmus MC, Rotterdam, The Netherlands.
Miranda de Graaf
Chris Lauber
Theo M Bestebroer
V Stalin Raj
Ali Moh Zaki
Albert D M E Osterhaus
Bart L Haagmans
Alexander E Gorbalenya
Eric J Snijder
Ron A M Fouchier
Erasmus MC · NLErasmus University Rotterdam · NLLeiden University Medical Center · NLLomonosov Moscow State University · RUSoliman Fakeeh Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledA novel human coronavirus (HCoV-EMC/2012) was isolated from a man with acute pneumonia and renal failure in June 2012. This report describes the complete genome sequence, genome organization, and expression strategy of HCoV-EMC/2012 and its relation with known coronaviruses. The genome contains 30,119 nucleotides and contains at least 10 predicted open reading frames, 9 of which are predicted to be expressed from a nested set of seven subgenomic mRNAs. Phylogenetic analysis of the replicase gene of coronaviruses with completely sequenced genomes showed that HCoV-EMC/2012 is most closely related to Tylonycteris bat coronavirus HKU4 (BtCoV-HKU4) and Pipistrellus bat coronavirus HKU5 (BtCoV-HKU5), which prototype two species in lineage C of the genus Betacoronavirus. In accordance with the guidelines of the International Committee on Taxonomy of Viruses, and in view of the 75% and 77% amino acid sequence identity in 7 conserved replicase domains with BtCoV-HKU4 and BtCoV-HKU5, respectively, we propose that HCoV-EMC/2012 prototypes a novel species in the genus Betacoronavirus. HCoV-EMC/2012 may be most closely related to a coronavirus detected in Pipistrellus pipistrellus in The Netherlands, but because only a short sequence from the most conserved part of the RNA-dependent RNA polymerase-encoding region of the genome was reported for this bat virus, its genetic distance from HCoV-EMC remains uncertain. HCoV-EMC/2012 is the sixth coronavirus known to infect humans and the first human virus within betacoronavirus lineage C. IMPORTANCE: Coronaviruses are capable of infecting humans and many animal species. Most infections caused by human coronaviruses are relatively mild. However, the outbreak of severe acute respiratory syndrome (SARS) caused by SARS-CoV in 2002 to 2003 and the fatal infection of a human by HCoV-EMC/2012 in 2012 show that coronaviruses are able to cause severe, sometimes fatal disease in humans. We have determined the complete genome of HCoV-EMC/2012 using an unbiased virus discovery approach involving next-generation sequencing techniques, which enabled subsequent state-of-the-art bioinformatics, phylogenetics, and taxonomic analyses. By establishing its complete genome sequence, HCoV-EMC/2012 was characterized as a new genotype which is closely related to bat coronaviruses that are distant from SARS-CoV. We expect that this information will be vital to rapid advancement of both clinical and vital research on this emerging pathogen.

Indexed as

Genome, ViralCluster AnalysisCoronavirusGene Expression Regulation, ViralGenes, ViralHumansMolecular Sequence DataNetherlandsOpen Reading FramesPhylogenyPneumonia, ViralRespiratory Distress SyndromeRNA, ViralSequence Analysis, DNASequence Homology, Amino AcidRNA, Viral

Identifiers

PMID23170002
PMCPMC3509437
OpenAlexW2113457186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.